相关实验视频

Updated: May 6, 2026

A Component-resolved Diagnostic Approach for a Study on Grass Pollen Allergens in Chinese Southerners with Allergic Rhinitis and/or Asthma

A Component-resolved Diagnostic Approach for a Study on Grass Pollen Allergens in Chinese Southerners with Allergic Rhinitis and/or Asthma

Published on: June 4, 2017

通过使用ALergy EXplorer (ALEX²) 宏观阵列,查喘患者的亚托皮状态

Robert G Hamilton¹, Mark Holbreich², Charles Bronzert¹

¹Johns Hopkins University School of Medicine, Johns Hopkins Asthma and Allergy Center, Baltimore, MD, USA.

The Journal of asthma : official journal of the Association for the Care of Asthma

|February 28, 2024

概括

过敏探险器 (ALEX2) 提供了比传统的Phadiatop查更详细的视图的喘患者的亚托皮状态. ALEX2发现了Phadiatop遗漏的其他过敏原敏感性,有助于个性化喘管理.

科学领域:

过敏和免疫学过敏和免疫学
肺部病理学肺部病理学
生物标志物发现发现

背景情况:

查喘患者的阿托皮是有效管理的关键.
自2010年以来,Phadiatop多种空气过敏原屏一直是标准的生物标志物.
过敏探测器 (ALEX2) 宏阵列是一个有前途的定量替代方案.

研究的目的:

评估使用ALEX2用于喘患者的亚托皮性查的优缺点.
将ALEX2的诊断性能与Phadiatop和ImmunoCAP测试进行比较.

主要方法:

在使用ImmunoCAP和ALEX2的喘儿童中评估了亚托皮状态 (IgE敏感化).
试验对象包括阿米什和赫特利特农场的孩子,他们的Phadiatop结果是模两可的或是阳性的.
ALEX2测试是对具有模两可的Phadiatop结果或总IgE升高的受试者进行的.

主要成果:

在44%的受试者中,ALEX2检测到Fadiatop遗漏的对过敏原 (虫,树花粉) 的IgE抗体,结果不明确,ImmunoCAP证实了这一点.
在Phadiatop阳性的受试者中,ALEX2在除了一个情况以外的所有情况下都证实了敏感性.
通过ALEX2检测到的特定IgE与环境暴露 (菌,子) 相关,并确定了交叉反应蛋白敏感性.

结论:

ALEX2提供了超越Phadiatop的增强特异性和详细的敏感化模式.
临床病史仍然是确认已识别的敏感性相关性的关键.
亚历克斯2可以改善对喘患者的敏感化和管理策略的解释.

关键词:

亚历克斯2 亚历克斯2 这就是法迪亚托普 (Phadiatop).亚托皮亚托皮亚亚托皮亚是什么意思宏观数组宏观数组是一个宏观数组.多种过敏原的屏幕.一个单复式的singleplex.

更多相关视频

Application of Biochip Microfluidic Technology to Detect Serum Allergen-specific Immunoglobulin E sIgE

Application of Biochip Microfluidic Technology to Detect Serum Allergen-specific Immunoglobulin E sIgE

Published on: April 21, 2019

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber

Published on: March 3, 2023

相关概念视频

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...

Asthma I: Introduction

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...